AEON Biopharma, Inc. Quarterly Operating Income (Loss) in USD from Q4 2020 to Q3 2024

Taxonomy & unit
us-gaap: USD
Description
The net result for the period of deducting operating expenses from operating revenues.
Summary
AEON Biopharma, Inc. quarterly/annual Operating Income (Loss) history and growth rate from Q4 2020 to Q3 2024.
  • AEON Biopharma, Inc. Operating Income (Loss) for the quarter ending September 30, 2024 was -$4.02M, a 98.6% increase year-over-year.
  • AEON Biopharma, Inc. annual Operating Income (Loss) for 2022 was -$48.4M, a 2402% decline from 2021.
Operating Income (Loss), Trailing 12 Months (USD)
Operating Income (Loss), Quarterly (USD)
Operating Income (Loss), YoY Quarterly Growth (%)
Period Value YoY Chg Change % Date Report Filed
Q3 2024 -$4.02M +$280M +98.6% Sep 30, 2024 10-Q 2024-11-13
Q2 2024 $153M +$156M Jun 30, 2024 10-Q 2024-08-12
Q1 2024 -$74.2M -$61.1M -468% Mar 31, 2024 10-Q 2024-05-14
Q3 2023 -$284M -$274M -2762% Sep 30, 2023 10-Q 2024-11-13
Q2 2023 -$2.63M -$2.2M -515% Jul 21, 2023 10-Q 2024-11-13
Q2 2023 -$14M -$13.5M -3170% Jun 30, 2023 10-Q 2024-08-12
Q1 2023 -$13M -$12.7M -3253% Mar 31, 2023 10-Q 2024-05-14
Q4 2022 -$37.7M -$36.8M -4156% Dec 31, 2022 10-K/A 2024-05-14
Q3 2022 -$9.91M -$9.46M -2099% Sep 30, 2022 10-Q/A 2024-03-29
Q2 2022 -$427K -$28.8K -7.22% Jun 30, 2022 10-Q 2023-07-21
Q1 2022 -$389K -$188K -93.7% Mar 31, 2022 10-Q 2023-05-17
Q4 2021 -$886K +$2.7M +75.3% Dec 31, 2021 10-K/A 2023-04-10
Q3 2021 -$451K Sep 30, 2021 10-Q 2022-11-14
Q2 2021 -$398K Jun 30, 2021 10-Q 2022-08-12
Q1 2021 -$201K Mar 31, 2021 10-Q 2022-05-12
Q4 2020 -$3.59M Dec 31, 2020 10-K 2022-03-28
* An asterisk sign (*) next to the value indicates that the value is likely invalid.